Alternatives to glycopyrrolate/formoterol
2 same-class SPL records vs glycopyrrolate/formoterol - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Bevespi Aerosphere
About glycopyrrolate/formoterol
Bevespi Aerosphere is a medicine that helps people with COPD breathe easier. It contains two medicines that work together to open airways.
Used for: Bevespi Aerosphere is used to help manage chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. This medicine helps to open your airways so you can breathe easier. It is not for sudden breathing problems.
2 LAMA / LABA Combination peers (wide set)
tiotropium/olodaterol
RxStiolto Respimat
Stiolto Respimat is used to treat chronic obstructive pulmonary disease (COPD). This includes chronic bronchitis and emphysema. This medicine helps you breathe better over a long period. Stiolto Respimat is not for sudden COPD symptoms or asthma.
umeclidinium/vilanterol
RxAnoro Ellipta
Anoro Ellipta is used to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. This medicine helps to open the airways in your lungs so you can breathe easier. It is not for sudden breathing problems.
Compare glycopyrrolate/formoterol vs tiotropium/olodaterol side-by-side →
glycopyrrolate/formoterol vs tiotropium/olodaterol & umeclidinium/vilanterol · FAERS reaction fields
FAERS top-reaction field "Difficulty breathing" shows the widest count spread between glycopyrrolate/formoterol and tiotropium/olodaterol, umeclidinium/vilanterol in this extract (1,000-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | glycopyrrolate/formoterol | tiotropium/olodaterol | umeclidinium/vilanterol |
|---|---|---|---|
| Difficulty breathing | 1,000 | - | - |
| Asthma | 793 | - | 604 |
| Wheezing | 674 | - | 325 |
| Cough | 626 | - | 701 |
| Pneumonia | 538 | - | 509 |
| Tiredness | 352 | - | 364 |
| Feeling unwell | 345 | - | 315 |
| Coughing up mucus | 330 | - | - |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
glycopyrrolate/formoterol peer mix vs class inventory
Peer mix
0 OTC and 2 Rx SPL records in this peer set (2 total). Class inventory for LAMA / LABA Combination: 3 drugs.
Frequently Asked Questions
What same-class SPL records sit beside glycopyrrolate/formoterol? ▼
Reading a wide LAMA / LABA Combination peer set (2 records)
glycopyrrolate/formoterol (Bevespi Aerosphere) sits in a wide LAMA / LABA Combination peer set (2 of 2 class peers shown). Labeled indication field for glycopyrrolate/formoterol: Bevespi Aerosphere is used to help manage chronic obstructive pulmonary disease (COPD).
Top FAERS reaction fields for glycopyrrolate/formoterol total 5,311 reports across 10 reactions, set beside tiotropium/olodaterol, umeclidinium/vilanterol. Counts are exposure-weighted submissions, not per-patient risk.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for glycopyrrolate/formoterol: see also the generic vs brand label guide when reading Bevespi Aerosphere SPL strings.
Read our methodology - how this data is sourced, computed, and verified.